Literature DB >> 21881113

Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.

Chadi M El Saleeby1, Andy J Bush, Lisa M Harrison, Jody A Aitken, John P Devincenzo.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) disease severity was thought to be a result of host immunopathology but alternatively may be driven by high-level viral replication. The relationships between RSV load, viral clearance dynamics, and disease severity have not been carefully evaluated.
METHODS: Previously healthy RSV-infected children <2 years old were recruited. RSV load was measured in respiratory secretions by fresh quantitative culture over 3 hospital days. Measures of disease severity were hospital admission, duration of hospitalization, requirement for intensive care, and respiratory failure.
RESULTS: Multivariate logistic regression models revealed independent predictors of increased duration of hospitalization: male sex, lower weight, and higher viral load on any day. Viral loads at day 3 were more significantly associated with requirement for intensive care and respiratory failure than were viral loads at earlier time points. Faster RSV clearance was independently associated with shorter hospitalization. DISCUSSION: These observations challenge the immunopathology-based pathogenesis paradigm. They also have major therapeutic implications, suggesting that application of antiviral agents early in the disease course, even at a time when viral replication is at its highest, might improve subsequent morbidity by significantly lowering viral load and direct viral cytopathic effects, and aborting the potential downstream immunopathology.

Entities:  

Mesh:

Year:  2011        PMID: 21881113      PMCID: PMC3203391          DOI: 10.1093/infdis/jir494

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants.

Authors:  Johan Löfgren; Mika Rämet; Marjo Renko; Riitta Marttila; Mikko Hallman
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

2.  A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children.

Authors:  Eun Hwa Choi; Hoan Jong Lee; Taiwoo Yoo; Stephen J Chanock
Journal:  J Infect Dis       Date:  2002-10-11       Impact factor: 5.226

3.  Viral load drives disease in humans experimentally infected with respiratory syncytial virus.

Authors:  John P DeVincenzo; Tom Wilkinson; Akshay Vaishnaw; Jeff Cehelsky; Rachel Meyers; Saraswathy Nochur; Lisa Harrison; Patricia Meeking; Alex Mann; Elizabeth Moane; John Oxford; Rajat Pareek; Ryves Moore; Ed Walsh; Robert Studholme; Preston Dorsett; Rene Alvarez; Robert Lambkin-Williams
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

4.  Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection.

Authors:  Meri Lahti; Johan Lofgren; Riita Marttila; Marjo Renko; Tuula Klaavuniemi; Ritva Haataja; Mika Ramet; Mikko Hallman
Journal:  Pediatr Res       Date:  2002-06       Impact factor: 3.756

5.  Bronchiolitis-associated hospitalizations among US children, 1980-1996.

Authors:  D K Shay; R C Holman; R D Newman; L L Liu; J W Stout; L J Anderson
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

6.  Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.

Authors:  S Aung; J A Rutigliano; B S Graham
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.

Authors:  T G Boyce; B G Mellen; E F Mitchel; P F Wright; M R Griffin
Journal:  J Pediatr       Date:  2000-12       Impact factor: 4.406

8.  Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.

Authors:  Shelah Leader; Kimmie Kohlhase
Journal:  Pediatr Infect Dis J       Date:  2002-07       Impact factor: 2.129

9.  Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms.

Authors:  Barbara Hoebee; Edwin Rietveld; Louis Bont; Marijke van Oosten; Hennie M Hodemaekers; Nico J D Nagelkerke; Herman J Neijens; Jan L L Kimpen; Tjeerd G Kimman
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

10.  A role for immune complexes in enhanced respiratory syncytial virus disease.

Authors:  Fernando P Polack; Michael N Teng; Peter L Collins; Gregory A Prince; Marcus Exner; Heinz Regele; Dario D Lirman; Richard Rabold; Scott J Hoffman; Christopher L Karp; Steven R Kleeberger; Marsha Wills-Karp; Ruth A Karron
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  98 in total

1.  Unbiased Detection of Respiratory Viruses by Use of RNA Sequencing-Based Metagenomics: a Systematic Comparison to a Commercial PCR Panel.

Authors:  Erin H Graf; Keith E Simmon; Keith D Tardif; Weston Hymas; Steven Flygare; Karen Eilbeck; Mark Yandell; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2016-01-27       Impact factor: 5.948

2.  Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.

Authors:  Lindsay Broadbent; Hong Guo Parke; Lyndsey J Ferguson; Andrena Millar; Michael D Shields; Laurent Detalle; Ultan F Power
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

3.  Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis.

Authors:  Luan D Vu; David Siefker; Tamekia L Jones; Dahui You; Ryleigh Taylor; John DeVincenzo; Stephania A Cormier
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

Review 4.  Respiratory Syncytial Virus Infection: An Illness for All Ages.

Authors:  Edward E Walsh
Journal:  Clin Chest Med       Date:  2016-12-27       Impact factor: 2.878

5.  Antibody response to respiratory syncytial virus infection in children <18 months old.

Authors:  Susanna Esposito; Elisa Scarselli; Mara Lelii; Alessia Scala; Alessandra Vitelli; Stefania Capone; Marco Fornili; Elia Biganzoli; Annalisa Orenti; Alfredo Nicosia; Riccardo Cortese; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

6.  Identification of two novel functional tRNA-derived fragments induced in response to respiratory syncytial virus infection.

Authors:  Jiehua Zhou; Shenxuan Liu; Yu Chen; Yu Fu; Alexander J Silver; Mark S Hill; Inhan Lee; Yong Sun Lee; Xiaoyong Bao
Journal:  J Gen Virol       Date:  2017-07-15       Impact factor: 3.891

7.  Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex.

Authors:  Alberto Jiménez-Somarribas; Shuli Mao; Jeong-Joong Yoon; Marco Weisshaar; Robert M Cox; Jose R Marengo; Deborah G Mitchell; Zachary P Morehouse; Dan Yan; Ivan Solis; Dennis C Liotta; Michael G Natchus; Richard K Plemper
Journal:  J Med Chem       Date:  2017-03-13       Impact factor: 7.446

8.  Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus infected infants.

Authors:  Monica E Brint; Joshua M Hughes; Aditya Shah; Chelsea R Miller; Lisa G Harrison; Elizabeth A Meals; Jacqueline Blanch; Charlotte R Thompson; Stephania A Cormier; John P DeVincenzo
Journal:  Pediatr Res       Date:  2017-08-09       Impact factor: 3.756

9.  Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection.

Authors:  Edward E Walsh; Lu Wang; Ann R Falsey; Xing Qiu; Anthony Corbett; Jeanne Holden-Wiltse; Thomas J Mariani; David J Topham; Mary T Caserta
Journal:  J Infect Dis       Date:  2018-06-20       Impact factor: 5.226

10.  Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.

Authors:  Dan Yan; Sujin Lee; Vidhi D Thakkar; Ming Luo; Martin L Moore; Richard Karl Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.